Anti-Aging Drugs Market Size

Anti-Aging Drugs Market size was valued at USD 59.75 billion in 2024 and is anticipated to reach USD 215.95 billion by the end of 2037, expanding at around 10.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of anti-aging drugs is assessed at USD 64.72 billion. The growth of the market can be attributed primarily to the rising aging population around the world with the rising hope for extending the healthy lifespan of humans having youthful characteristics. According to the World Health Organization, globally, the percentage of people over 60 years of age will nearly double from 12% to 22% between 2015 and 2050.

In the prevention and treatment of age-related disorders and diseases, anti-aging drugs combine advanced biotechnology and clinical prevention medicines. Anti-aging drugs are mostly used by the baby boomer generation, as well as by consumers who care more about their health and appearance. Using these drugs, the body is able to reverse the effects of aging. The aging process is also being delayed through a wide variety of medical technologies.